IHE
Equity
iShares U.S. Pharmaceuticals ETF
- NAV as ofJun 15, 2026
- $93.7052 WK: 64.74 - 95.05
- 1 Day NAV Change as ofJun 15, 2026
- Decrease $
-1.09(-1.15%)
- Jun 12, 2026
- YTD: Increase
12.18%
- May 31, 2026
- 1.21%
- May 31, 2026
- 1.62%
- Expense Ratio:Fees as stated in the prospectus
- 0.38%
- 4 stars
- NAV as ofJun 15, 2026
- $93.7052 WK: 64.74 - 95.05
- 1 Day NAV Change as ofJun 15, 2026
- Decrease $
-1.09(-1.15%)
- Jun 12, 2026
- YTD: Increase
12.18%
- May 31, 2026
- 1.21%
- May 31, 2026
- 1.62%
- Expense Ratio:Fees as stated in the prospectus
- 0.38%
- 4 stars
The iShares U.S. Pharmaceuticals ETF seeks to track an index of U.S. companies in the pharmaceuticals sector. The fund offers a way for invstors to express a high-conviction view to domestic drug manufacturers and vaccine producers.
Key Facts
Net Assets of Fund
Closing Price
Exchange
NYSE Arca
Benchmark Index
Dow Jones U.S. Select Pharmaceuticals Index
Shares Outstanding
10,350,000
as of Jun 15, 2026